BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 35367964)

  • 1. Exploring Network Properties Across Preclinical Stages of Alzheimer's Disease Using a Visual Short-Term Memory and Attention Task with High-Density Electroencephalography: A Brain-Connectome Neurophysiological Study.
    Lazarou I; Georgiadis K; Nikolopoulos S; Oikonomou VP; Stavropoulos TG; Tsolaki A; Kompatsiaris I; Tsolaki M;
    J Alzheimers Dis; 2022; 87(2):643-664. PubMed ID: 35367964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Connectome-Based Electrophysiological Study of Subjective Cognitive Decline Related to Alzheimer's Disease by Using Resting-State High-Density EEG EGI GES 300.
    Lazarou I; Georgiadis K; Nikolopoulos S; Oikonomou VP; Tsolaki A; Kompatsiaris I; Tsolaki M; Kugiumtzis D
    Brain Sci; 2020 Jun; 10(6):. PubMed ID: 32575641
    [No Abstract]   [Full Text] [Related]  

  • 3. Network Disruption in the Preclinical Stages of Alzheimer's Disease: From Subjective Cognitive Decline to Mild Cognitive Impairment.
    López-Sanz D; Garcés P; Álvarez B; Delgado-Losada ML; López-Higes R; Maestú F
    Int J Neural Syst; 2017 Dec; 27(8):1750041. PubMed ID: 28958179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is brain connectome research the future frontier for subjective cognitive decline? A systematic review.
    Lazarou I; Nikolopoulos S; Dimitriadis SI; Yiannis Kompatsiaris I; Spilioti M; Tsolaki M
    Clin Neurophysiol; 2019 Oct; 130(10):1762-1780. PubMed ID: 31401485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disrupted morphological brain network organization in subjective cognitive decline and mild cognitive impairment.
    Chen Y; Liang L; Wei Y; Liu Y; Li X; Zhang Z; Li L; Deng D
    Brain Imaging Behav; 2024 Apr; 18(2):387-395. PubMed ID: 38147273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The compensatory phenomenon of the functional connectome related to pathological biomarkers in individuals with subjective cognitive decline.
    Chen H; Sheng X; Luo C; Qin R; Ye Q; Zhao H; Xu Y; Bai F;
    Transl Neurodegener; 2020 May; 9(1):21. PubMed ID: 32460888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A network approach to subjective cognitive decline: Exploring multivariate relationships in neuropsychological test performance across Alzheimer's disease risk states.
    Grunden N; Phillips NA; ;
    Cortex; 2024 Apr; 173():313-332. PubMed ID: 38458017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A metabolism-functional connectome sparse coupling method to reveal imaging markers for Alzheimer's disease based on simultaneous PET/MRI scans.
    Wang L; Xu H; Wang M; Brendel M; Rominger A; Shi K; Han Y; Jiang J
    Hum Brain Mapp; 2023 Dec; 44(17):6020-6030. PubMed ID: 37740923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From Subjective Cognitive Decline to Alzheimer's Disease: The Predictive Role of Neuropsychological Assessment, Personality Traits, and Cognitive Reserve. A 7-Year Follow-Up Study.
    Bessi V; Mazzeo S; Padiglioni S; Piccini C; Nacmias B; Sorbi S; Bracco L
    J Alzheimers Dis; 2018; 63(4):1523-1535. PubMed ID: 29782316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
    Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electroencephalography-based classification of Alzheimer's disease spectrum during computer-based cognitive testing.
    Kim SK; Kim H; Kim SH; Kim JB; Kim L
    Sci Rep; 2024 Mar; 14(1):5252. PubMed ID: 38438453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine - A predictor for five year-mortality in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia.
    Futschek IE; Schernhammer E; Haslacher H; Stögmann E; Lehrner J
    Exp Gerontol; 2023 Feb; 172():112045. PubMed ID: 36509298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disentangling empathy impairment along Alzheimer's disease continuum: From subjective cognitive decline to Alzheimer's dementia.
    Giacomucci G; Moschini V; Piazzesi D; Padiglioni S; Caruso C; Nuti C; Munarin A; Mazzeo S; Galdo G; Polito C; Emiliani F; Frigerio D; Morinelli C; Bagnoli S; Ingannato A; Nacmias B; Sorbi S; Berti V; Bessi V
    Cortex; 2024 Mar; 172():125-140. PubMed ID: 38301390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Face-Name Associative Recognition Deficits in Subjective Cognitive Decline and Mild Cognitive Impairment.
    Polcher A; Frommann I; Koppara A; Wolfsgruber S; Jessen F; Wagner M
    J Alzheimers Dis; 2017; 56(3):1185-1196. PubMed ID: 28106560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early diagnosis of mild cognitive impairment and Alzheimer's with event-related potentials and event-related desynchronization in N-back working memory tasks.
    Fraga FJ; Mamani GQ; Johns E; Tavares G; Falk TH; Phillips NA
    Comput Methods Programs Biomed; 2018 Oct; 164():1-13. PubMed ID: 30195417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latent patterns of task-related functional connectivity in relation to regions of hyperactivation in individuals at risk of Alzheimer's disease.
    Corriveau-Lecavalier N; Rajah MN; Mellah S; Belleville S
    Neuroimage Clin; 2021; 30():102643. PubMed ID: 33813263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma neurofilament light chain as a biomarker of Alzheimer's disease in Subjective Cognitive Decline and Mild Cognitive Impairment.
    Giacomucci G; Mazzeo S; Bagnoli S; Ingannato A; Leccese D; Berti V; Padiglioni S; Galdo G; Ferrari C; Sorbi S; Bessi V; Nacmias B
    J Neurol; 2022 Aug; 269(8):4270-4280. PubMed ID: 35288777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 7T amygdala and hippocampus subfields in volumetry-based associations with memory: A 3-year follow-up study of early Alzheimer's disease.
    Göschel L; Kurz L; Dell'Orco A; Köbe T; Körtvélyessy P; Fillmer A; Aydin S; Riemann LT; Wang H; Ittermann B; Grittner U; Flöel A
    Neuroimage Clin; 2023; 38():103439. PubMed ID: 37253284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between composite scores of domain-specific cognitive functions and regional patterns of atrophy and functional connectivity in the Alzheimer's disease spectrum.
    Amaefule CO; Dyrba M; Wolfsgruber S; Polcher A; Schneider A; Fliessbach K; Spottke A; Meiberth D; Preis L; Peters O; Incesoy EI; Spruth EJ; Priller J; Altenstein S; Bartels C; Wiltfang J; Janowitz D; Bürger K; Laske C; Munk M; Rudolph J; Glanz W; Dobisch L; Haynes JD; Dechent P; Ertl-Wagner B; Scheffler K; Kilimann I; Düzel E; Metzger CD; Wagner M; Jessen F; Teipel SJ
    Neuroimage Clin; 2021; 29():102533. PubMed ID: 33360018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Neuropsychological Performance and CSF Profile in Subjective Cognitive Decline: Towards the Diagnosis of Preclinical AD.
    Chipi E; Bellomo G; Salvadori N; Montanucci C; Gaetani L; Paolini Paoletti F; Parnetti L
    J Prev Alzheimers Dis; 2023; 10(3):523-529. PubMed ID: 37357293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.